Assessment of Clinical, Service, and Cost Outcomes of a Conversion Program of Sumatriptan to Rizatriptan ODT in Primary Care Patients With Migraine Headaches

OBJECTIVES: Managed care organizations can increase the value of drug therapy by negotiating discounts on drug acquisition costs with pharmaceutical manufacturers and promoting use of preferred drugs, including the conversion of patients to preferred medications. This investigation was designed to a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gershovich, Olga E., Billups, Sarah J., Delate, Thomas, Hoffman, Caroline Kicklighter, Carroll, Nikki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2006
Materias:
Formulary Management
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438095/
https://www.ncbi.nlm.nih.gov/pubmed/16623609
http://dx.doi.org/10.18553/jmcp.2006.12.3.246

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438095/
https://www.ncbi.nlm.nih.gov/pubmed/16623609
http://dx.doi.org/10.18553/jmcp.2006.12.3.246

Ejemplares similares